Common Contracts
2 similar Master Development Agreement contracts by Cancer Prevention Pharmaceuticals, Inc.
EX-10.26 40 filename40.htmMaster Development Agreement • May 5th, 2020 • Delaware
Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 406 of the Securities Act of 1933, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission
ContractMaster Development Agreement • December 23rd, 2015 • Cancer Prevention Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 406 of the Securities Act of 1933, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission
